Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GSK

FTSE 100 Live 30 October: Next forecasts £1bn profit, GSK vaccine sales weakness hits shares

A £1 billion profits landmark for Next and strong trading at Standard Chartered today provided FTSE 100 cheer during another painful session for GSK investors.

Evening Standard

FTSE 100 Live 28 October: Oil price slide hits BP and Shell, Trainline upgrades guidance

A 5% slide in the price of Brent Crude today ensured BP and Shell led the fallers board during an otherwise resilient session for the FTSE 100 index.

Evening Standard

Stock market today: Wall Street retreats from records

Traders around the word awaited U.S. inflation data for September—and the implications it will have for rate cuts at the Federal Reserve's November meeting.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

GSK strikes $2.2bn deal to resolve legal cases in US over heartburn treatment Zantac

British drugmaker agrees payment to resolve 80,000 cases alleging cancers were linked to drug known generically as ranitidine

The Guardian - UK

The Hidden Power Of Spinoffs: Why They Continue To Outperform

CVS just announced it was considering a breakup. Why is that important? Spinoffs are one of the best-kept investment secrets, despite the fact that many investors typically disregard them and frequently outperform more general markets.

Barchart

RSV can be deadly—especially for older adults. Why aren’t more of them getting the new vaccine?

About 6,000 to 10,000 people 65 and older die from RSV in the U.S. annually, the CDC says.

Fortune

Prince Harry Is Set to Return to the U.K. in Under 2 Weeks

We can likely expect a short trip.

Marie Claire

Read news from The Economist, FT, and more,
with one subscription

You Can Stop Looking, Here's the Perfect Stock for the Current Market

While technology stocks continue to struggle, stocks in the lucrative over-the-counter healthcare products sector are thriving. One prominent such name is Haleon. Its stock has jumped more than 22% over the past three months, as sales and profits in its nine large-scale multinational, high-margin 'power brands' continue to hold leading…

Barchart

CDC issues new guidelines for RSV vaccines, citing side-effect concerns

The CDC has clarified and narrowed its recommendations for which older adults should get an RSV vaccine.

LiveScience

GSK’s health is improving. Shame about the legal heartburn

Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share price becalmed

The Guardian - UK

XDefiant Factions Guide: Everything You Need To Know

This XDefiant factions guide helps players know what the different factions specialize in and what abilities they provide during combat.

Player One

Bird flu isn’t spreading in humans for now. But there are vaccines in the pipeline if that changes

Since May, a number of poultry farms around Australia have faced outbreaks of avian influenza, or bird flu. These outbreaks have been devastating for the poultry farms affected, necessitating large-scale culls, and have caused knock-on effects for the country’s egg supplies.

The Conversation

A 'new era' in malaria control has begun with a vaccination campaign for children in Ivory Coast

Health workers in Ivory Coast have begun giving children the latest malaria vaccine

The Independent UK

US service sector shrinks for first time since May 2020; UK private sector growth slows in ‘pre-election seize up’ – as it happened

Eurozone private sector also loses momentum

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Can I take antihistamines everyday? More than the recommended dose? What if I’m pregnant? Here’s what the research says

Allergies happen when your immune system overreacts to a normally harmless substance like dust or pollen. Hay fever, hives and anaphylaxis are all types of allergic reactions.

Al Jazeera

As big pharma exits Nigeria, asthma patients face spiralling costs

Price of asthma inhalers has more than doubled amid scarcity and added costs after GSK exited Nigerian market in 2023.

LiveScience

New RSV shots tied to rare nervous system disorder — should you worry?

There's been some reports of Guillain-Barré syndrome in older adults who got the vaccines. But health officials still recommend that this population get the shots, in consultation with their doctors.

StockNews.com

3 Value Stocks to Buy for Bargain Hunters

Amid macroeconomic challenges like high inflation, recession threats, and global uncertainties, value stocks such as GSK (GSK), Expedia Group (EXPE), and Albertsons (ACI) offer promising opportunities for savvy bargain hunters. Read on.

Get all your
news in one place.

100's of premium titles.
One news app.

Evening Standard

FTSE 100 Live 3 June: New York trading glitch sparks volatility, GSK shares tumble

BP and Shell shares today hindered FTSE 100 progress after oil prices fell to their lowest level since February.

Medical Daily

Guillain-Barre Syndrome 'More Common Than Expected' In RSV Vaccinated Older Adults: CDC

While the U.S. Food and Drug Administration (FDA) and the officials from the CDC continue to investigate the risks, the current recommendation is to continue the vaccine as "the estimated benefits of RSV vaccination continued to outweigh potential risks."

StockNews.com

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

Evening Standard

FTSE 100 Live 17 May: LandSec shares fall on results, GSK in £1.25bn final Haleon stake sale

GSK and Land Securities are in the FTSE 100 spotlight after the drugs giant sold its final Haleon shares and the property firm posted results.

The Guardian - UK

‘The issue is when to pull the trigger’: how prepared are we for human bird flu?

The H5N1 virus has been devastating bird populations, and is now infecting mammals too. Is human-to-human transmission next? And are we ready for another pandemic?

WEKU

Could better asthma inhalers help patients, and the planet too?

Some doctors are promoting propellant-free inhalers over puff inhalers that emit greenhouse gases. Climate change can exacerbate respiratory ills because of more fires, air pollution and allergens.

StockNews.com

The pharmaceutical industry is set for solid growth due to increased demand for effective treatments for regular and rare diseases, an aging population, and ongoing innovations in pharma technology. Hence, investors could consider buying quality pharmaceutical stocks such as Collegium Pharmaceutical (COLL), Novo Nordisk (NVO), and GSK (GSK). Read on.

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.